Treatment of depression. Desvenlafaxine succinate is not indicated for use in the pediatric population. Major depressive disorder: Desvenlafaxine is indicated for the treatment of major depressive disorder (MDD) in men and women. Vasomotor symptoms associated with menopause: Desvenlafaxine is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Desvenlafaxine is an alternative to hormonal treatment for the management of vasomotor symptoms, but is not a substitute for hormonal treatment when indicated.
Reviews
There are no reviews yet.